Tatsuo Watanabe Selected Research

Tatsuo Watanabe Research Topics

Disease

9	Rheumatoid Arthritis 03/2024 - 01/2016
9	Inflammation (Inflammations) 08/2021 - 01/2004
7	Fever (Fevers) 02/2020 - 01/2004
6	Neoplasms (Cancer) 02/2020 - 02/2008
6	Body Weight (Weight, Body) 08/2011 - 12/2003
5	Contact Dermatitis (Eczema, Contact) 05/2020 - 02/2009
4	Periodontitis 01/2009 - 06/2006
4	Hypothermia 04/2008 - 01/2004
3	Obesity 09/2019 - 12/2003
2	Neuroblastoma 02/2023 - 02/2020
2	Bradycardia 11/2019 - 06/2016
2	Periodontal Diseases (Periodontal Disease) 05/2013 - 03/2004
1	Respiratory Syncytial Virus Infections 02/2023
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 02/2023
1	Polyps 12/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2020
1	Intellectual Disability (Idiocy) 09/2020
1	Brain Neoplasms (Brain Tumor) 02/2020
1	Neutropenia 02/2020
1	Hematologic Neoplasms (Hematological Malignancy) 02/2020
1	Febrile Neutropenia 02/2020
1	Philadelphia Chromosome 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Abdominal Pain (Pain, Abdominal) 02/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Ependymoma 01/2018
1	Necrosis 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Thyroid Neoplasms (Thyroid Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

10	LipopolysaccharidesIBA 10/2011 - 01/2004
5	lenvatinibIBA 01/2019 - 02/2008
5	CytokinesIBA 03/2011 - 01/2004
4	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 02/2019
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2008
4	Angiotensin IIIBA 01/2013 - 01/2004
4	8-Hydroxy-2'-DeoxyguanosineIBA 10/2011 - 10/2007
3	Fluorescein-5-isothiocyanate (FITC)IBA 05/2020 - 11/2012
3	isothiocyanic acidIBA 05/2020 - 02/2009
3	Fluorescein (Funduscein)FDA LinkGeneric 05/2020 - 02/2009
3	EstersIBA 01/2015 - 11/2012
3	phthalic acid (phthalate)IBA 01/2015 - 11/2012
3	capsiateIBA 03/2012 - 12/2003
3	Capsaicin (Zostrix)FDA Link 03/2012 - 01/2011
3	Peptide Hydrolases (Proteases)FDA Link 10/2011 - 10/2007
3	PyrogensIBA 10/2011 - 01/2004
3	Triglycerides (Triacylglycerol)IBA 10/2008 - 03/2004
2	baricitinibIBA 08/2021 - 12/2020
2	C-Reactive ProteinIBA 08/2021 - 02/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 07/2006
2	Abatacept (Orencia)FDA Link 11/2019 - 09/2019
2	Bevacizumab (Avastin)FDA Link 01/2018 - 09/2008
2	AnkyrinsIBA 01/2017 - 11/2012
2	oleuropeinIBA 01/2017 - 10/2008
2	salicylhydroxamic acid (SHAM)IBA 09/2014 - 01/2013
2	Indicators and Reagents (Reagents)IBA 05/2013 - 03/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 10/2007
2	Dibutyl Phthalate (Butyl Phthalate)IBA 11/2012 - 02/2009
2	gingerolIBA 03/2011 - 04/2008
2	Dinoprostone (PGE2)FDA Link 03/2011 - 01/2004
2	Natriuretic PeptidesIBA 05/2010 - 09/2006
2	CholesterolIBA 10/2008 - 06/2006
2	Phosphotransferases (Kinase)IBA 09/2008 - 02/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2008 - 02/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 01/2004
2	Interleukin-1 (Interleukin 1)IBA 11/2006 - 01/2004
2	Atrial Natriuretic Factor (ANF)IBA 11/2006 - 09/2006
2	InterleukinsIBA 09/2006 - 03/2004
2	Peptides (Polypeptides)IBA 07/2006 - 01/2004
2	Interleukin-1beta (Interleukin 1 beta)IBA 06/2006 - 03/2004
1	tocilizumab (atlizumab)FDA Link 08/2021
1	Janus Kinase InhibitorsIBA 08/2021
1	Prostaglandins AIBA 08/2021
1	MicroplasticsIBA 12/2020
1	piperineIBA 05/2020
1	Piperacillin FDA LinkGeneric 02/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	Superoxide DismutaseIBA 11/2019
1	CosmeticsIBA 09/2019
1	ORALIT (ORS)IBA 02/2019
1	TantalumIBA 02/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	pazopanib FDA Link 01/2017
1	Ifosfamide FDA LinkGeneric 01/2017
1	MuscimolIBA 06/2016
1	Atropine FDA LinkGeneric 06/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 11/2015
1	Capsules (Microcapsules)IBA 11/2015

Therapy/Procedure

3	Therapeutics 03/2024 - 01/2014
3	Drug Therapy (Chemotherapy) 02/2023 - 01/2020
3	Toothbrushing 01/2009 - 09/2002
2	Transplantation 02/2023 - 09/2020
1	Hematopoietic Stem Cell Transplantation 02/2023
1	Biological Therapy 04/2019
1	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2019
1	Proton Therapy 01/2018
1	Intravenous Administration 06/2016